• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORPORATION ARTZ DISPO; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORPORATION ARTZ DISPO; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem Unspecified Infection (1930)
Event Date 01/29/2019
Event Type  Injury  
Manufacturer Narrative
According to the injecting physician, there were no issues on aseptic manipulation of the injection.It was considered that the septic arthritis was possibly related to artz dispo.Company comment: we are requesting further information on the case.All of product batches passed with the release test including the sterility test before the product release.It is therefore highly unlikely that the product quality was related to the septic arthritis.Manufacturer's causality assessment is determined as "not related".(b)(4).
 
Event Description
On (b)(6) 2019: a (b)(6) year-old female patient received an injection of artz dispo for left gonarthrosis.On (b)(6) 2019: she had septic arthritis.2019-unk - she was admitted and had an operation at another hospital.
 
Event Description
(b)(6) 2019 - a 58 year-old female patient received an injection of artz dispo for left gonarthrosis.(b)(6) 2019 - she had septic arthritis.2019-unk - she was admitted and had an operation at another hospital.Unk - she recovered.
 
Manufacturer Narrative
According to the injecting physician, there were no issues on aseptic manipulation of the injection.It was considered that the septic arthritis was possibly related to artz dispo.Company comment: this is a definitive report.The physician denies to provide further information.The outcome was changed "recovered " from "recovering".All of product batches passed with the release test including the sterility test before the product release.It is therefore highly unlikely that the product quality was related to the septic arthritis.Manufacturer's causality assessment is determined as "not related".We selected the code of 4316(appropriate term/code not available) for h.6 manufacturer evaluation conclusion code because the reported adverse event was not listed in the package insert and concerned lot number was not available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTZ DISPO
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
SEIKAGAKU CORPORATION
marunouchi center building
6-1, marunouchi 1-chome
chiyoda-ku, tokyo 100-0 005
JA  100-0005
MDR Report Key9828943
MDR Text Key190516646
Report Number9612392-2020-00003
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
PMA/PMN Number
P980044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 02/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/13/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received03/26/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age58 YR
-
-